SINOPHARM GROUP CO LTDSINOPHARM GROUP CO LTDSINOPHARM GROUP CO LTD

SINOPHARM GROUP CO LTD

No trades
See on Supercharts

X2S fundamentals

SINOPHARM GROUP CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of X2S for the last semiannual is 38.17 B EUR, and it's 3.05% higher compared to the previous semiannual. The net income of H1 24 is 479.74 M EUR.

‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth